Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lysine acetylsalicylate for aspirin resistance in type 2 diabetes
NCT01935193Phase 4Unknown
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Nov 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lysine acetylsalicylate, sponsored by AOU Città della Salute e della Scienza di Torino. Status: unknown.
02
Drugs
lysine acetylsalicylate
Beyond the preview
Go deeper on NCT01935193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935193.